Nonrespiratory complications of nusinersen-treated spinal muscular atrophy type 1 patients

Moran Lavie*, Mika Rochman, Liora Sagi, Anat Yerushalmy Feler, Dror Ovadia, Michal Cahal, Moria Be'er, Efraim Sadot, Aviva Fattal-Valevski, Israel Amirav

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Fingerprint

Dive into the research topics of 'Nonrespiratory complications of nusinersen-treated spinal muscular atrophy type 1 patients'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science